Status:
TERMINATED
Bupivacaine Plus Diclofenac Versus Bupivacaine Alone for Postoperative Pain Relief in Gynecologic Cancer Patients
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
Post-operative Pain
Eligibility:
FEMALE
21-70 years
Phase:
NA
Brief Summary
compare the postoperative pain between Bupivacaine peritoneal Infiltration plus immediately postoperative intramuscular Diclofenac and Bupivacaine peritoneal infiltration alone by using visual analogu...
Detailed Description
The primary objective is to compare the postoperative pain between Bupivacaine peritoneal Infiltration plus immediately postoperative intramuscular Diclofenac and Bupivacaine peritoneal infiltration a...
Eligibility Criteria
Inclusion
- gynecologic cancer patients ,i.e. cervical cancer, endometrial cancer, or ovarian tumor suspicious for malignancy
- who has scheduled for operation via laparotomy route
- Women who has ASA physical status I-II
- All of the have age more than 20 years old
- able to communicate in Thai
- Women who agrees to participate in this study
Exclusion
- patient who had emergency conditions - indication for emergency operation
- intraoperative cardiac arrhythmia
- operation purpose for only tumor biopsy
- Women who have abnormal kidney function test (Cr \> 1.5)
- Women with history of gastrointestinal bleeding
- Women who take the antiplatelet or anticoagulant medications
- Women with history of allergy to bupivacaine and NSAIDs
- Women who cannot evaluated pain score
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03796403
Start Date
February 15 2019
End Date
December 30 2019
Last Update
October 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajavithi hospital
Bangkok, Thailand, 10400